Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis

Brain

Volumn 138, Issue 6, 2015, Pages 1568-1582

  Abdel Aziz, Khaled ^a   Schneider, Torben ^a   Solanky, Bhavana S ^a   Yiannakas, Marios C ^a   Altmann, Dan R ^a,b   Wheeler Kingshott, Claudia A M ^a   Peters, Amy L ^a   Day, Brian L ^a   Thompson, Alan J ^a,c   Ciccarelli, Olga ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Biomarkers; Cellular mechanisms; Multiple sclerosis imaging

Indexed keywords

GLUTAMIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; GLUTAMINE; N-ACETYLASPARTATE;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; BODY POSTURE; BRAIN SIZE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; GRIP STRENGTH; HUMAN; MALE; MODIFIED ASHWORTH SCALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS WALKING SCALE 12; NERVE DEGENERATION; NEUROIMAGING; NINE HOLE PEG TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SPINAL CORD; TIMED 25 FOOT WALK TEST; VIBRATION SENSE; WHITE MATTER; ADOLESCENT; ANALOGS AND DERIVATIVES; ATROPHY; BRAIN; CASE CONTROL STUDY; EARLY DIAGNOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; ATROPHY; BRAIN; CASE-CONTROL STUDIES; CERVICAL CORD; DISABILITY EVALUATION; EARLY DIAGNOSIS; FEMALE; GLUTAMIC ACID; GLUTAMINE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVE DEGENERATION; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SPINAL CORD; WHITE MATTER; YOUNG ADULT;

EID: 84938704530     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv086     Document Type: Article

References (72)

1. Anaby D, Duncan ID, Smith CM, Cohen Y. q-Space diffusion MRI (QSI) of the disease progression in the spinal cords of the Long Evans shaker: diffusion time and apparent anisotropy. NMR Biomed 2013; 26: 1879-86.
2. Assaf Y, Ben-Bashat D, Chapman J, Peled S, Biton IE, Kafri M, et al High b-value q-space analyzed diffusion-weighted MRI: application to multiple sclerosis. Magn Reson Med 2002; 47: 115-26
3. Assaf Y, Chapman J, Ben-Bashat D, Hendler T, Segev Y, Korczyn AD, et al. White matter changes in multiple sclerosis: correlation of qspace diffusion MRI and 1H MRS. Magn Reson Imaging 2005; 23: 703-10
4. Assaf Y, Cohen Y. Assignment of the water slow-diffusing component in the central nervous system using q-space diffusion MRS: implications for fiber tract imaging. Magn Reson Med 2005; 43: 191-99
5. Assaf Y, Mayk A, Cohen Y. Displacement imaging of spinal cord using q-space diffusion-weighted MRI. Magn Reson Med 2000; 44: 713-22
6. Baker EH, Basso G, Barker PB, Smith MA, Bonekamp D, Horska A Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging 2008; 27: 489-99
7. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed 2002; 15: 435-55
8. Bieniek M, Altmann DR, Davies GR, Ingle GT, Rashid W, Sastre-Garriga J, et al. Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 1036-39
9. Biton IE, Duncan ID, Cohen Y. High b-value q-space diffusion MRI in myelin-deficient rat spinal cords. Magn Reson Imaging 2006; 24: 161-66
10. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced Nacetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893-901
11. Blamire AM, Cader S, Lee M, Palace J, Matthews PM. Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 2007; 58: 880-5
12. Bodini B, Cercignani M, Toosy A, Stefano ND, Miller DH, Thompson AJ, et al. A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS. Hum Brain Mapp 2013; 35: 723-33
13. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-7
14. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-98
15. Bunn LM, Marsden JF, Giunti P, Day BL. Stance instability in spinocerebellar ataxia type 6. Mov Disord 2013; 28: 510-16
16. Callaghan PT, Eccles CD, Xia Y. NMR microscopy of dynamic displacements: k-space and q-space imaging. J Phy E Sci Instrum 1988; 21: 820
17. Caramanos Z, Narayanan S, Arnold DL. 1H-MRS quantification of tNA and tCR in patients with multiple sclerosis: a meta-analytic review. Brain 2005; 128: 2483-506
18. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010; 32: 223-8
19. Ciccarelli O, Altmann DR, McLean MA, Wheeler-Kingshott CA, Wimpey K, Miller DH, et al. Spinal cord repair in MS: does mitochondrial metabolism play a role? Neurology 2010; 74: 721-7
20. Ciccarelli O, Barkhof F, Bodini B, De Stefano N, Golay X, Nicolay K, et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol 2014; 13: 807-22
21. Ciccarelli O, Thomas D, De Vita E, Wheeler-Kingshott C, Kachramanoglou C, Kapoor R, et al. Low myo-inositol indicating astrocytic damage in a case series of NMO. Ann Neurol 2013; 74: 301-5
22. Ciccarelli O, Wheeler-Kingshott CA, McLean MA, Cercignani M, Wimpey K, Miller DH, et al. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis Brain 2007; 130: 2220-31
23. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-8
24. Cottrell DA, Kremenchutzky M, Rice GP, Koopman WJ, Hader W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 2000; 122: 625-39
25. Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122: 871-82
26. Day BL, Steiger MJ, Thompson PD, Marsden CD. Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway. J Physiol 1993; 469: 479-99
27. Edden RA, Bonekamp D, Smith MA, Dubey P. Barker PB Proton MR spectroscopic imaging of the medulla and cervical spinal cord J Magn Reson Imaging 2007; 26: 1101-5
28. Farrell JA, Smith SA, Gordon-Lipkin EM, Reich DS, Calabresi PA, van Zijl PC. High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: feasibility and application to multiple sclerosis. Magn Reson Med 2008; 59: 1079-89
29. Farrell JA, Zhang J, Jones MV, Deboy CA, Hoffman PN, Landman BA, et al. q-space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy. Magn Reson Med 2010; 63: 1323-35
30. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250
31. Fox RJ, Thompson A, Baker D, Baneke P, Brown D, Browne P, et al Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler 2012; 18: 1534-40
32. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 2006; 55: 1219-26
33. Goodkin DE, Hertsgaard D, Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-andblock and nine-hole peg tests. Arch Phys Med Rehabil 1988; 69: 850-4
34. Hancu I. Optimized glutamate detection at 3T. J Magn Reson Imaging 2009; 30: 1155-62
35. Henning A, Schar M, Kollias SS, Boesiger P, Dydak U. Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med 2008; 59: 1250-8
36. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R. Thompson AJ Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-6
37. Horsfield MA, Sala S, Neema M, Absinta M, Bakshi A, Sormani MP, et al. Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis Neuroimage 2010; 50: 446-55
38. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 2004; 51: 435-40
39. Kaiser LG, Schuff N, Cashdollar N, Weiner MW. Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging 2005; 26: 665-72
40. Kearney H, Yiannakas MC, Abdel-Aziz K, Wheeler-Kingshott CA, Altmann DR, Ciccarelli O, Miller DH. Improved MRI quantification of spinal cord atrophy in multiple sclerosis. J Magn Reson Imaging 2013; 39: 617-23
41. Kearney H, Yiannakas MC, Samson RS, Wheeler-Kingshott CA, Ciccarelli O, Miller DH. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord. Brain 2014; 137: 2456-68
42. Khaleeli Z, Ciccarelli O, Manfredonia F, Barkhof F, Brochet B, Cercignani M, et al. Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol 2008; 63: 790-3
43. Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2007; 78: 1076-82
44. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52
45. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119: 701-8
46. Marliani AF, Clementi V, Albini-Riccioli L, Agati R, Leonardi M Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 tesla. Magn Reson Med 2007; 57: 160-3
47. Marliani AF, Clementi V, Albini Riccioli L, Agati R, Carpenzano M, Salvi F, Leonardi M. Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 2010; 31: 180-4
48. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. NAcetylaspartate in the CNS: from neurodiagnostics to neurobiology Prog Neurobiol 2007; 81: 89-131
49. Muhlert N, Atzori M, De Vita E, Thomas DL, Samson RS, Wheeler-Kingshott CA, et al. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry 2014; 85: 833-9
50. Oh J, Saidha S, Chen M, Smith SA, Prince J, Jones C, et al. Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology 2013; 80: 540-7
51. Ourselin S, Roche A, Prima S, Ayache N. Block Matching: a general framework to improve robustness of rigid registration of medical images. In: Delp S, DiGoia A, Jaramaz B, editors. Medical Image Computing and Computer-Assisted Intervention-MICCAI 2000 Vol. 1935. Berlin Heidelberg: Springer; 2000. p. 557-66
52. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998; 316: 1236-8
53. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-6
54. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-9
55. Provencher SW. LCModel & LCMgui User's Manual. Vol. 2014 2014. Available from http://s-provencher.com/pub/LCModel/manual/manual.pdf.
56. Ramio-Torrenta L, Sastre-Garriga J, Ingle GT, Davies GR, Ameen V, Miller DH, et al. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006; 77: 40-5
57. Rothman KJ. No adjustments are needed for multiple comparisons Epidemiology 1990; 1: 43-6
58. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117-34
59. Sastre-Garriga J, Ingle GT, Chard DT, Ramio-Torrenta L, McLean MA, Miller DH, et al. Metabolite changes in normalappearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 2005; 62: 569-73
60. Schneider T, Ciccarelli O, Kachramanoglou C, Thomas DL, Wheeler-Kingshott CAM. Reliability of tract-specific q-space imaging metrics in healthy spinal cord. Proc Intl Soc Mag Reson Med 2011; 66
61. Smith SA, Levante TO, Meier BH, Ernst RR. Computer-simulations in magnetic-resonance-an object-oriented programming approach J Magn Reson A 1994; 106: 75-105
62. Solanky BS, Abdel-Aziz K, Yiannakas MC, Berry AM, Ciccarelli O, Wheeler-Kingshott CA. In vivo magnetic resonance spectroscopy detection of combined glutamate-glutamine in healthy upper cervical cord at 3 T. NMR Biomed 2013; 26: 357-66
63. Stein J, Narendran K, McBean J, Krebs K, Hughes R Electromyography-controlled exoskeletal upper-limb-powered orthosis for exercise training after stroke. Am J Phys Med Rehabil 2007; 86: 255-61
64. Svens B, Lee H. Intra-and inter-instrument reliability of Grip-Strength Measurements: GripTrack™ and Jamar® hand dynamometers. Br J Hand Ther 2005; 10: 47-55
65. Tench CR, Morgan PS, Constantinescu CS. Measurement of cervical spinal cord cross-sectional area by MRI using edge detection and partial volume correction. J Magn Reson Imaging 2005; 21: 197-203
66. Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000; 47: 831-5
67. Wansapura JP, Holland SK, Dunn RS, Ball WS. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging 1999; 9: 531-8
68. Wheeler-Kingshott CA, Stroman PW, Schwab JM, Bacon M, Bosma R, Brooks J, et al. The current state-of-the-art of spinal cord imaging: applications. Neuroimage 2014; 84: 1082-93
69. Wilm BJ, Svensson J, Henning A, Pruessmann KP, Boesiger P, Kollias SS. Reduced field-of-view MRI using outer volume suppression for spinal cord diffusion imaging. Magn Reson Med 2007; 57: 625-30
70. Wu YC, Field AS, Duncan ID, Samsonov AA, Kondo Y, Tudorascu D, Alexander AL. High b-value and diffusion tensor imaging in a canine model of dysmyelination and brain maturation Neuroimage 2011; 58: 829-37
71. Yiannakas MC, Kearney H, Samson RS, Chard DT, Ciccarelli O, Miller DH, et al. Feasibility of grey matter and white matter segmentation of the upper cervical cord in vivo: a pilot study with application to magnetisation transfer measurements. Neuroimage 2012; 63: 1054-59
72. Zackowski KM, Smith SA, Reich DS, Gordon-Lipkin E, Chodkowski BA, Sambandan DR, et al. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transferimaging abnormalities in the spinal cord. Brain 2009; 132: 1200-9.